Search clinical trials for: OPB-111001

Total 1889 results

Otsuka Pharmaceutical Co., Ltd.

Completed

A Dose-defining Study of OPC-41061 in Treatment of Hepatic Edema

Cirrhosis

Japan
National Institute of Mental Health (NIMH)

Recruiting

Characterization of an Optically Pumped Magnetometer (OPM) Magnetoencephalography (MEG) Array

Normal Physiology

United States
University of Colorado, Denver
University of Colorado, Boulder

Recruiting

A Room Temperature Atomic Magnetrode System for Telemetry of Epileptic Seizures

Epilepsy

United States
Dorothy Kessler

Completed

Creating Satisfying Engagement in Daily Life Through Coaching for People With Multiple Sclerosis

Quality of Life | Multiple Sclerosis

Canada
Anthea Hospital Bari

Completed

Jafron Haemoadsorption During Cardiopulmonary Bypass (JAFRONCPB)

Cytokine Release Syndrome

Italy
Otsuka Pharmaceutical Co., Ltd.

Completed

To Investigate the Efficacy and Safety of OPC-6535 in Chronic Obstructive Pulmonary Disease (COPD) Patients

Chronic Obstructive Pulmonary Disease

China, Japan, Korea, Republic of
Hapten Sciences, Inc.

Completed

A Phase I, Single-Center Study of PDC-APB in Healthy Volunteers

Contact Dermatitis

United States
Yale University

Completed

Using Capnography to Reduce Hypoxia During Pediatric Sedation

Hypoxia | Hypoventilation

United States
Ottawa Hospital Research Institute
University of Ottawa

Completed

Occupational Performance Coaching for Stroke Survivors

Stroke

Canada
VA Office of Research and Development

Not yet recruiting

Strengthening Neuro-Cognitive Skills for Success in School, Work and Beyond

Cognitive Dysfunction | TBI

United States
Bandim Health Project
March of Dimes; Danida

Completed

Sex-Differential Health Interventions In Low-Birth-Weight Infants

Mortality | Growth | Morbidity | Neonatal Mortality

Guinea-Bissau
University of Pennsylvania

Completed

COVID-19 Vaccine Text Outreach

Covid19

United States
Otsuka Pharmaceutical Co., Ltd.

Completed

A Long-term Trial of OPA-15406 in Infants With Atopic Dermatitis

Atopic Dermatitis (AD)

Japan
Sahlgrenska University Hospital, Sweden

Completed

Impact of Cardiopulmonary Bypass Flow on Renal Oxygenation, Blood Flow and Tubular Injury (ICAROX2)

Renal Failure | Inflammatory Response | Hemolysis | Cardiopulmonary Bypass | Extracorporeal Circulation; Complications | Circulation Disorder | Renal Plasma Flow, Effective

Sweden
IRCCS San Raffaele Roma
Ettore Sansavini Health Science Foundation

Completed

Effects on Organ Damage and Surgical Outcome of a New Cardiopulmonary Pass System (EVADO) (EVADO)

C.Surgical Procedure; Cardiac

Italy
Otsuka Pharmaceutical Co., Ltd.

Completed

A Phase I, Open-Label Trial to Assess the Absorption, Metabolism, and Excretion of (14C)-OPC-61815 in Healthy Male Japanese Subjects

Healthy Adult Male

United Kingdom
Otsuka Pharmaceutical Co., Ltd.

Completed

Safety Trial of OPC-61815 Injection in Patients With Congestive Heart Failure Who Have Difficulty With or Are Incapable of Oral Intake

Congestive Heart Failure

Japan
Otsuka Pharmaceutical Co., Ltd.

Completed

A Dose-finding and Confirmatory Trial of OPC-6535 in Patients With Active Crohn's Disease

Crohn's Disease

Korea, Republic of, Japan
Otsuka Pharmaceutical Co., Ltd.

Completed

A Clinical Trial to Assess Three Different Doses of OPS-2071 in Patients With Bacterial Enteritis

Bacterial Enteritis

Korea, Republic of, Singapore, Japan
Otsuka Pharmaceutical Co., Ltd.

Terminated

A Dose-finding Study of OPC-6535 in Patients With Active Crohn's Disease

Crohn Disease

Japan
Otsuka Pharmaceutical Co., Ltd.

Completed

Study of OPA-15406 Ointment in Patients With Atopic Dermatitis

Atopic Dermatitis

Japan
Otsuka Pharmaceutical Co., Ltd.

Completed

A Dose-finding Trial of OPC-34712 in Patients With Schizophrenia

Schizophrenia

Japan
Otsuka Pharmaceutical Co., Ltd.

Completed

A Phase 1,Open -Label Study to Assess the Absorption, Metabolism and Excretion of 14C-OPS-2071 Following a Single Oral Dose to Healthy Male Japanese Subjects

Bacterial Enteritis

United Kingdom
Upstream Bio Inc.

Completed

Safety and Blood Levels After a Single Injection of UPB-101 in Healthy Japanese and Non-Japanese Non-East Asian Adults

Healthy

United Kingdom
Isa Naina Mohamed
Malaysia Palm Oil Board

Completed

Supplementation of Oil Palm Phenolics to Improve Lipid Profile in Subjects With Minor Hyperlipidaemia

Hypercholesterolemia | Hyperlipidemias

Malaysia
Otsuka Pharmaceutical Development & Commercialization...

Completed

A Study to Evaluate the Effectiveness and Safety of Topical OPA-15406 Ointment to Treat Participants With Atopic Dermatitis

Atopic Dermatitis

Poland, United States, Australia
Otsuka Pharmaceutical Co., Ltd.

Completed

Comparison Trial of OPA-15406 Ointment in Adult Patients With Atopic DermatitisSyndrome

Atopic Dermatitis

Japan
KCRI
SIS Medical AG

Completed

Optimal Lesion Preparation With Non-compliant Balloons Before Implantation Of Bioresorbable Scaffolds (OPreNBiS)

Coronary Artery Disease | Angina, Stable | Angina, Unstable

Switzerland
Ilam University of Medical Sciences

Completed

The Effect of Educational Intervention on Delivery Type Selection in Pregnant Women at Kermanshah, Iran

Pregnancy
Otsuka Pharmaceutical Development & Commercialization...

Completed

FACTS I: A Study to Test the Safety and Effectiveness of a New Medication on the Treatment of Active Ulcerative Colitis

Ulcerative Colitis

United States
Hapten Sciences, Inc.
Milton S. Hershey Medical Center

Not yet recruiting

A Safety, Tolerability, and Dermal Reactogenicity Study of PDC-APB

Contact Dermatitis
University of Illinois at Chicago
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); University...

Completed

A Sleep Intervention in Type 1 Diabetes

Type1diabetes | Short Sleep Phenotype

United States
Wake Forest University Health Sciences

Completed

Flavonoid Supplementation and Endothelial Function

Healthy
University of Oulu

Unknown

Acute Lung Injury After Aortic Valve Surgery

Lung Injury

Finland
Otsuka Frankfurt Research Institute GmbH

Completed

Safety, Efficacy and Pharmacokinetics of OPC-67683 in Patients With Pulmonary Tuberculosis

Pulmonary Tuberculosis

South Africa
Ohana BioSciences

Unknown

Randomized, Standard-Controlled, Study to Evaluate the Ohana IVF Sperm Preparation Kit, SPeRtility IVF Next Generation (SPRING)

Infertility | Infertility, Male

United States
Elizabeth Kelley
Children's Hospital of Eastern Ontario; McMaster Children's Hospital; Holland... and other collaborators

Not yet recruiting

OPT-IN: Online Parent Training Intervention for Young Children Diagnosed With Autism Spectrum Disorder

Autism Spectrum Disorder
University of Illinois at Chicago
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Recruiting

Sleep Optimization to Improve Glycemic Control in Adults With Type 1 Diabetes (SOPT)

Type 1 Diabetes

United States
Tongji Hospital
Guangdong Provincial Hospital of Traditional Chinese Medicine; Fudan University and other collaborators

Recruiting

Comparing Laparoscopic and Open Surgery for Pancreatic Carcinoma

Pancreatic Carcinoma | Pancreaticoduodenectomy | Laparoscopic

China
University of Aarhus
Steno Diabetes Center Aarhus, Aarhus University Hospital, Denmark; Department...

Completed

Pre-meals of 3-hydroxybutyrate in Type 2 Diabetes (PreKetone)

Ketosis | Postprandial Hyperglycemia | Glucose Metabolism Disorders (Including Diabetes Mellitus)

Denmark
Oppilan Pharma Ltd

Active, not recruiting

VTX002 Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis

Colitis, Ulcerative

United States, Bulgaria, Czechia, France, Georgia, Germany, Hungary, India, Italy, Korea, Republic of, Lithuania, Poland, Serbia, Slovakia
Chung Shan Medical University
National Taichung University of Education

Completed

Functional Food Application of Okara Protein Hydrolysate (OPH)- for Anti-exercise-fatigue

Healthy

Taiwan
University of Aarhus

Completed

Metabolic Differences of an Oral and Intravenous Dose of 3-hydroxybutyrate (3-OHB).

Healthy | Incretin Effect | Ketosis

Denmark
Otsuka Pharmaceutical Development & Commercialization...

Completed

FACTS II: A Study to Test the Safety and Effectiveness of a New Medication on the Treatment of Active Ulcerative Colitis

Ulcerative Colitis

United States
VA Puget Sound Health Care System

Not yet recruiting

Opt-in vs. Opt-out for Breast Cancer Screening

Breast Cancer

United States
Gabriele Baldini, MD, MSc, Assistant Professor

Completed

Sublingual Microcirculation and Postoperative Ileus

Inflammatory Bowel Diseases | Colorectal Cancer | Gastrointestinal Dysfunction

Canada
Otsuka Pharmaceutical Co., Ltd.

Completed

A Phase 2 Trial of OPC-64005 for Major Depressive Disorder

Major Depressive Disorder

Japan
Otsuka Pharmaceutical Development & Commercialization...

Terminated

Ascending Dose Study of OPC-108459 Intravenous Infusions in Patients With Paroxysmal and Persistent Atrial Fibrillation (CADENCE 215)

Atrial Fibrillation | Paroxysmal Atrial Fibrillation | Persistent Atrial Fibrillation

United States, Italy, Germany, Netherlands, Spain, United Kingdom
Medway NHS Foundation Trust

Completed

Cystoscopy and Cystodistension; Therapeutic and Aetiological Aspect in Overactive Bladder

Urinary Incontinence, Urge

United Kingdom
Alcon Research

Completed

Evaluation of FID 114657 in Sjogren's Syndrome Subjects

Sjogren's Syndrome

Search clinical trials for: OPB-111001

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Equatorial Guinea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations